Novan, Inc. (NOVN)

5.45
NASDAQ
Prev Close 5.45
Day Low/High 0.00 / 0.00
52 Wk Low/High 3.52 / 30.90
Exchange NASDAQ
Shares Outstanding 15.94B
Market Cap 81.29M
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT: Investigation Of Novan Announced By Holzer & Holzer

INVESTOR ALERT: Investigation Of Novan Announced By Holzer & Holzer

Holzer & Holzer, LLC is investigating whether certain statements issued by Novan Inc.

Anne Whitaker Named CEO Of KNOW Bio Respiratory Company

Anne Whitaker Named CEO Of KNOW Bio Respiratory Company

Targets Cystic Fibrosis using Novel Nitric Oxide Technology

Novan is Now Oversold (NOVN)

Novan is Now Oversold (NOVN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

What's Next for Novan After Its IPO?

What's Next for Novan After Its IPO?

The pharma company is only getting started, says CEO Nate Stasko.

Novan Only Piercing the Skin of Its Potential Says CEO

Novan Only Piercing the Skin of Its Potential Says CEO

With a pair of Phase III trials coming up for its dermatological drug, Novan CEO Nate Stasko says the company is merely piercing the skin of its long-term potential.

Novan Announces Both SB204 Phase 3 Pivotal Trials Fully Enrolled

Novan Announces Both SB204 Phase 3 Pivotal Trials Fully Enrolled

More than 2,600 Subjects Enrolled Ahead of Schedule

Novan Announces Closing Of Initial Public Offering

Novan Announces Closing Of Initial Public Offering

Underwriters Exercised in Full Option to Purchase Additional Shares

Jim Cramer's Trust Sells Out of AbbVie: What Wall Street's Saying

Jim Cramer's Trust Sells Out of AbbVie: What Wall Street's Saying

Jim Cramer's charitable trust closed out its position in AbbVie on Tuesday, citing concerns for its 'expensive' acquisition plans for Pharmacylics.

'Mad Money Lightning Round': Stick With UPS

'Mad Money Lightning Round': Stick With UPS

Cramer likes UPS and Fedex.

Cramer's 'Mad Money' Recap: Jamie Dimon's Prophetic Call (Final)

Cramer's 'Mad Money' Recap: Jamie Dimon's Prophetic Call (Final)

Cramer says JPMorgan's CEO is correct in saying that economy is on the road to recovery. Click for news from Jim Cramer.

Today's Lists on Stockpickr

Here's what stood out in the market today.

Noven Soars 22% on Acquisition (Update)

The deal values Noven at $16.50 a share, a 22% premium to its closing price Monday.

Movers Roundup: First Solar, Zions Bancorp

Movers roundup: First Solar drops as analyst sees weak Europe demand, Zions Bancorp higher

Noven Shares Rise As Analyst Boosts Outlook

Noven Pharmaceuticals shares rise as Jefferies analyst upgrades stock on sales potential

Noven And Shire Recall 39 Lots Of ADHD Patches

Noven and Shire say 39 lots of Daytrana patch have been recalled due to substandard liners

Sara Lee Insider Sells $19.4 Million

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Linda Sanford Sells $2.68 Million of IBM

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Insider: Big Buys at BofA, JPMorgan

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.